FAS and type 2 diabetes mellitus: Lower expression levels of ACC-1 and FAS were observed in T2DM mice after treatment with SPPE, and these mRNA levels in the SPPE250 group were close to those in the normal group, indicating that SPPE could modulate liver lipid metabolism by suppressing fatty acid synthesis and fat accumulation.